TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22564009

Group type: EXPERIMENTAL
Intervention: Quiet eye training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Technical training
Number of subjects: 40
Study: 20237953

Group type: EXPERIMENTAL
Intervention: Respiratory feedback (RFB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-contingent respiratory feedback (placebo)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: RFB
Number of subjects: 42
Study: 18024579

Group type: EXPERIMENTAL
Intervention: Endovascular coiling
Number of subjects: 73

Group type: COMPARATOR
Intervention: Surgical clipping
Number of subjects: 73
Study: 16038246

Group type: EXPERIMENTAL
Intervention: Mw vaccine (1 x 10^9 heat killed bacilli for the first dose, 5 x 10^8 for the second dose, given 6 months apart)
Number of subjects: 24060

Group type: EXPERIMENTAL
Intervention: Mw vaccine (when both patients and contacts received the vaccine)
Number of subjects: 24060

Group type: EXPERIMENTAL
Intervention: Mw vaccine (when only patients received the vaccine)
Number of subjects: 24060

Group type: COMPARATOR
Intervention: Placebo (1/8th dose of normal dose of tetanus toxoid)
Number of subjects: 24060
Study: 11929147

Group type: EXPERIMENTAL
Intervention: Best-fit regression formula (CrExcr1)
Number of subjects: 885

Group type: COMPARATOR
Intervention: Cockroft-Gault formula (CrExcr2)
Number of subjects: 885

Group type: EXPERIMENTAL
Intervention: Measured creatinine excretion (CrExcr)
Number of subjects: 885
Study: 10336576

Group type: EXPERIMENTAL
Intervention: Sibrafiban 2 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Sibrafiban 5-12 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Sibrafiban 5-7 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Sibrafiban 12 mg
Number of subjects: 4
Study: 7482386

Group type: EXPERIMENTAL
Intervention: benazepril 10 mg (BZ 10)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: benazepril 5 mg/hydrochlorothiazide 6.25 mg (BZ + HCTZ)
Number of subjects: 71

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 71
Study: 1963134

Group type: EXPERIMENTAL
Intervention: Different drugs for reducing occlusion frequency after coronary artery bypass
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical analysis using logistic regression
Number of subjects: 0
Study: 6440658

Group type: EXPERIMENTAL
Intervention: Bacampicillin 4.8 g with probenecid 1 g
Number of subjects: 63

Group type: COMPARATOR
Intervention: Amoxycillin 3 g with probenecid 1 g
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: N meningitidis isolated from the pharynx
Number of subjects: 63
Study: 31368282

Group type: EXPERIMENTAL
Intervention: Tongdu Tiaoshen needling combined with swallowing training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine swallowing training
Number of subjects: 100
Study: 29077584

Group type: EXPERIMENTAL
Intervention: delefilcon A
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: narafilcon A
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: omafilcon A
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: nesofilcon A
Number of subjects: 27
Study: 26809751

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 911

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 911
Study: 24811543

Group type: EXPERIMENTAL
Intervention: Task-specific fall prevention training program (six 30-minute sessions over 2 weeks)
Number of subjects: 14
Study: 23513559

Group type: EXPERIMENTAL
Intervention: CLNP‐BPO5/TZ
Number of subjects: 40

Group type: COMPARATOR
Intervention: CLNP‐BPO2.5/TZ
Number of subjects: 40
Study: 21085635

Group type: EXPERIMENTAL
Intervention: Therapeutic immunization with Tat
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (observational study)
Number of subjects: 87
Study: 18635912

Group type: EXPERIMENTAL
Intervention: Kampo (combination of ginseng, oriental bezoar, and glycyrrhiza)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 16847795

Group type: EXPERIMENTAL
Intervention: Subcutaneous terbutaline while maintaining oxytocin infusion
Number of subjects: 29

Group type: COMPARATOR
Intervention: Oxytocin discontinuation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Subcutaneous terbutaline and oxytocin
Number of subjects: 29
Study: 14565653

Group type: EXPERIMENTAL
Intervention: DVP (daunorubicin 45 mg/m2 daily, days 1, 2 and 3; prednisone 60 mg/m2 daily orally days 1‐35; vincristine 2 mg intravenously on days 1, 8, 15 and 22)
Number of subjects: 276

Group type: COMPARATOR
Intervention: DATVP (daunorubicin 60 mg/m2 daily, days 1, 2 and 3; cytarabine 25 mg/m2 intravenous bolus followed by 200 mg/m2 daily as a continuous infusion on days 1‐5; 6-thioguanine 100 mg/m2 orally every 12 h on days 1‐5; vincristine 2 mg intravenously on days 1 and 8; prednisone 60 mg/m2/day orally, days 1‐7)
Number of subjects: 276
Study: 11083681

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Celiprolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Albuterol (800 microg)
Number of subjects: 12
Study: 22302887

Group type: EXPERIMENTAL
Intervention: Caffeine (500 mg test dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (48 h substitution)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Caffeine metabolism rate
Number of subjects: 40
Study: 2070285

Group type: EXPERIMENTAL
Intervention: Relaxation session (20 mins lying down listening to a tape)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured interview (the structured interview of Rosenman)
Number of subjects: 0
Study: 6215496

Group type: EXPERIMENTAL
Intervention: EMG biofeedback training
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Relaxation training with no feedback
Number of subjects: 15

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 15
Study: 30529737

Group type: EXPERIMENTAL
Intervention: Pilates group (PEP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Muscular group (MEP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study: 26830893

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Program (CBP)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 316
Study: 27761556

Group type: EXPERIMENTAL
Intervention: Propofol/alfentanil (10 µg/kg IV alfentanil)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Propofol/ketamine (0.5 mg/kg IV ketamine)
Number of subjects: 52
Study: 24976448

Group type: EXPERIMENTAL
Intervention: Coadministration of rosuvastatin 10 mg with metformin 750 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Monoadministration of rosuvastatin 10 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Monoadministration of metformin 750 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All treatments (rosuvastatin, metformin, and coadministration)
Number of subjects: 36
Study: 22212240

Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg administered 30 min prior to exercise)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 16
Study: 20707767

Group type: EXPERIMENTAL
Intervention: Solifenacin (5 or 10 mg/day, flexibly dosed)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 17627692

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG‐IUS)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Thermal balloon ablation (TBA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 66
Study: 15899022

Group type: EXPERIMENTAL
Intervention: Tooth-coloured post-and-core with composite core (Tetric Ceram)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Zirconia post (Cosmopost) with composite core (Tetric Ceram)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Zirconia post (Cosmopost) with custom made ceramic core (Cosmo Ingot)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glass fibre-reinforced post (FRC Postec) with composite core (Tetric Ceram)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group: root-filled incisors without posts
Number of subjects: 50
Study: 12073726

Group type: EXPERIMENTAL
Intervention: Fortify (surface sealant)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Unibond (low-viscosity resin system)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fluorseal (low-viscosity resin system)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no surface sealing)
Number of subjects: 50
Study: 10384580

Group type: EXPERIMENTAL
Intervention: Randomized controlled clinical trial evidence
Number of subjects: 76

Group type: COMPARATOR
Intervention: Locally developed recommendations
Number of subjects: 76

Group type: COMPARATOR
Intervention: No evidence
Number of subjects: 76
Study: 7644734

Group type: EXPERIMENTAL
Intervention: APCT
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lipiodol‐CT
Number of subjects: 18
Study: 2663957

Group type: EXPERIMENTAL
Intervention: Urinary sheath system 1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Urinary sheath system 2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Urinary sheath system 3
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no sheath system)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Overall performance of urinary sheath systems
Number of subjects: 6
Study: 402275

Group type: EXPERIMENTAL
Intervention: Phentolamine infusion during surgery with glucose load (20 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ringer's lactate solution infusion during surgery with glucose load (20 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ringer's lactate solution and phentolamine infusion during surgery (control group)
Number of subjects: 0
Study: 31335204

Group type: EXPERIMENTAL
Intervention: Euglyca mobile application
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine calculations (Control group)
Number of subjects: 80
Study: 26833853

Group type: EXPERIMENTAL
Intervention: Nordic walking training (NW)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Free walk (FW)
Number of subjects: 33
Study: 25590308

Group type: EXPERIMENTAL
Intervention: Saline spray
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Squeeze bottle
Number of subjects: 86
Study: 24015773

Group type: EXPERIMENTAL
Intervention: Loss-framed antismoking PSA
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Gain-framed antismoking PSA
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Secondhand smoke PSA
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Smoking addiction PSA
Number of subjects: 183
Study: 21792057

Group type: EXPERIMENTAL
Intervention: Topical cyclosporine A (0.05%) twice a day plus preservative-free artificial tears four times a day for 4 months
Number of subjects: 42

Group type: COMPARATOR
Intervention: Preservative-free artificial tears four times a day for 4 months
Number of subjects: 42
Study: 19327530

Group type: EXPERIMENTAL
Intervention: Diazoxide (100 micromol/L)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16637752

Group type: EXPERIMENTAL
Intervention: Symhedonia for high-attachment targets
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sympathy
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sympathy and symhedonia
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Symhedonia
Number of subjects: 7
Study: 12910806

Group type: EXPERIMENTAL
Intervention: Thermal bath plus muds (Group A)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Thermal bath plus muds (Group C)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 18
Study: 11198133

Group type: EXPERIMENTAL
Intervention: Single own brand cigarette
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (abstained smokers)
Number of subjects: 0
Study: 8813910

Group type: EXPERIMENTAL
Intervention: Unoplast Unometer 500
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Braun Ureofix 511
Number of subjects: 45

Group type: COMPARATOR
Intervention: Kendall Curity 4000
Number of subjects: 45
Study: 1563054

Group type: EXPERIMENTAL
Intervention: Nasal prongs (Group NP, 4 L.min‐1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Simple facemask (Group FM, 8 L.min‐1)
Number of subjects: 40
Study: 4054191

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 18
Study: 30135030

Group type: EXPERIMENTAL
Intervention: Etifoxine (100 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 30
Study: 27902584

Group type: EXPERIMENTAL
Intervention: naloxone+fentanyl
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: tropisetron+fentanyl
Number of subjects: 90

Group type: COMPARATOR
Intervention: fentanyl
Number of subjects: 90
Study: 24773915

Group type: EXPERIMENTAL
Intervention: Topical cream delivering narrow-band ultraviolet B, average of 38 sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22549370

Group type: EXPERIMENTAL
Intervention: Transvaginal cholecystectomy (TVC)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Single incision laparoscopic cholecystectomy (SILC)
Number of subjects: 47
Study: 20353858

Group type: EXPERIMENTAL
Intervention: Collagenase injection for MCP joint contracture
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Collagenase injection for PIP joint contracture
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Overall clinical success rating
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Initial response to collagenase injection
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Long-term recurrence rates
Number of subjects: 8
Study: 18561583

Group type: EXPERIMENTAL
Intervention: Solubilized BPO 5% gel
Number of subjects: 23

Group type: COMPARATOR
Intervention: BPO 5%/clindamycin 1% combination product
Number of subjects: 23
Study: 14759375

Group type: EXPERIMENTAL
Intervention: Low-dose alteplase (50 mg) and tirofiban (0.4 microg/kg/min/30 minute bolus; infusion of 0.1 microg/kg/minute)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard strategy with either full-dose alteplase (100 mg) or stenting PCI
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Stenting PCI with tirofiban
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard stenting PCI
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Conjunctive regimens with tirofiban
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard regimens
Number of subjects: 144
Study: 10918826

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 0
Study: 9293416

Group type: EXPERIMENTAL
Intervention: Seat tube angle of 80 degrees
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Seat tube angle of 74 degrees
Number of subjects: 14
Study: 7688432

Group type: EXPERIMENTAL
Intervention: 100 mg pentosanpolysulfate 3 times per day
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 3523457

Group type: EXPERIMENTAL
Intervention: Ceftazidime (CZ) at a dose of 150 mg/kg/day divided every 8 hours
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ceftazidime (CZ)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional treatment with chloramphenicol and ampicillin (CA)
Number of subjects: 100
Study: 29316962

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (Marx protocol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standard care with antibiotics and chlorhexidine mouthwash)
Number of subjects: 0
Study: 26385164

Group type: EXPERIMENTAL
Intervention: In SHAPE lifestyle intervention
Number of subjects: 192
Study: 24978428

Group type: EXPERIMENTAL
Intervention: 0.3 mg ranibizumab
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.5 mg ranibizumab
Number of subjects: 10

Group type: COMPARATOR
Intervention: Untreated fellow eye
Number of subjects: 10
Study: 22934592

Group type: EXPERIMENTAL
Intervention: Web-based interactive curriculum emphasizing conciseness and clinical reasoning
Number of subjects: 132

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: All students after receiving the curriculum
Number of subjects: 132

Group type: COMPARATOR
Intervention: Untrained comparison students
Number of subjects: 132
Study: 19408097

Group type: EXPERIMENTAL
Intervention: New-Alfare
Number of subjects: 47
Study: 18417739

Group type: EXPERIMENTAL
Intervention: Tipifarnib administered concurrently with radiation therapy at dose levels ranging from 100 to 150 mg/m(2)/dose, followed by adjuvant tipifarnib at 200 mg/m(2)/dose for 21 consecutive days in 28-day cycles.
Number of subjects: 17
Study: 15923005

Group type: EXPERIMENTAL
Intervention: Early oral feeding (8 h)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Delayed oral feeding (24 h)
Number of subjects: 151
Study: 12534646

Group type: EXPERIMENTAL
Intervention: Amprenavir 600 mg twice a day for 10 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Delavirdine 600 mg twice a day for 10 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both amprenavir and delavirdine for 10 days
Number of subjects: 18
Study: 11244724

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride 100 mg/d
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (ordinary medication only)
Number of subjects: 49
Study: 9253881

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mebendazole (400 mg single dose)
Number of subjects: 0
Study: 1514652

Group type: EXPERIMENTAL
Intervention: Bromides (BR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Phenobarbitone (PB) and/or Phenytoin (PHT)
Number of subjects: 120
Study: 6424697

Group type: EXPERIMENTAL
Intervention: Tailored elimination diets
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Oral sodium cromoglycate (SCG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 31018921

Group type: EXPERIMENTAL
Intervention: Exercise intervention (203 minutes/week)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Mind-body control group (23 minutes/week)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 49
Study: 28815717

Group type: EXPERIMENTAL
Intervention: Endoscopic partial inferior turbinectomy (EPIT) with rhinoseptoplasty
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rhinoseptoplasty without EPIT
Number of subjects: 50
Study: 26766564

Group type: EXPERIMENTAL
Intervention: Azilsartan medoxomil (AZL‐M) 80mg
Number of subjects: 3821

Group type: COMPARATOR
Intervention: Olmesartan (OLM) 40mg
Number of subjects: 3821

Group type: COMPARATOR
Intervention: Valsartan (VAL) 320mg
Number of subjects: 3821

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3821
Study: 24261926

Group type: EXPERIMENTAL
Intervention: Lumbar stabilization exercises (LSE)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Manual therapy (MT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Lumbar stabilization exercises (LSE) with modified CPR (mCPR)
Number of subjects: 105
Study: 21666432

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg/d) for 6 months
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Donepezil PET examinations
Number of subjects: 80
Study: 19725485

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection with lidocaine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Lidocaine alone
Number of subjects: 63
Study: 17261398

Group type: EXPERIMENTAL
Intervention: Distal protection during PCI
Number of subjects: 194

Group type: COMPARATOR
Intervention: No distal protection during PCI
Number of subjects: 194
Study: 15056486

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotic treatment over 14 weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotic treatment
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (healthy controls, N=73)
Number of subjects: 66
Study: 11317071

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 205

Group type: COMPARATOR
Intervention: Control (no HAART)
Number of subjects: 205
Study: 9338672

Group type: EXPERIMENTAL
Intervention: Transscleral diode laser photocoagulation (wavelength 810 nm)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Transpupillary diode laser photocoagulation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Transscleral diode laser photocoagulation
Number of subjects: 25
Study: 7960384

Group type: EXPERIMENTAL
Intervention: Decreasing frequency categories
Number of subjects: 6783

Group type: EXPERIMENTAL
Intervention: Addition of portion sizes
Number of subjects: 6783

Group type: EXPERIMENTAL
Intervention: Inclusion of additional non-dietary questions
Number of subjects: 6783
Study: 2820626

Group type: EXPERIMENTAL
Intervention: CGS 14824A (2 mg p.o. q.d.)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: CGS 14824A (10 mg p.o. q.d.)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 6
Study: 29860453

Group type: EXPERIMENTAL
Intervention: Breastfeeding promotion intervention
Number of subjects: 13392

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 13392

Group type: EXPERIMENTAL
Intervention: Maternal age at birth
Number of subjects: 13392

Group type: EXPERIMENTAL
Intervention: Urban versus rural residence
Number of subjects: 13392

Group type: EXPERIMENTAL
Intervention: Lower parental education and number of older siblings
Number of subjects: 13392

Group type: EXPERIMENTAL
Intervention: Gender (boys vs girls)
Number of subjects: 13392
Study: 27435610

Group type: EXPERIMENTAL
Intervention: Active treatment (transcutaneous electrical stimulation)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Active treatment (transcutaneous electrical stimulation) in mild-to-moderate OSA subgroup
Number of subjects: 36
Study: 25258014

Group type: EXPERIMENTAL
Intervention: Low-fat diet (20% kcal)
Number of subjects: 48835